giang nidqc
☆    

Vietnam,
2018-09-27 10:55
(2028 d 09:07 ago)

Posting: # 19329
Views: 1,368
 

 Spiramycine [Bioanalytics]

Post reply
Dear all,
I've been looking for any guidance of BE study for spiramycine but have not found anything. I found some articles, some used microbiological assay, some used HPLC methods (detect all 3 components or only Spiramycine I). As spiramycine have 3 main components (I: 85%, II: 5%; III: 10%), all have therapeutic effect, what APIs do we need to measure: all of these components individually, or just Spiramycine I?
THanks in advance!
 
UA Flag
Activity
 Admin contact
22,984 posts in 4,822 threads, 1,651 registered users;
53 visitors (0 registered, 53 guests [including 4 identified bots]).
Forum time: 20:02 CEST (Europe/Vienna)

You can’t fix by analysis
what you bungled by design.    Richard J. Light, Judith D. Singer, John B. Willett

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5